|
|
|||||||||||||||
Prompt diagnosis of bacterial meningitis in children improves their chances of survival. However, many primary healthcare workers have limited training. Researchers at the MRC Laboratories in the Gambia and the London School of Hygiene and Tropical Medicine assessed guidelines to help health workers make these important decisions. Acute bacterial meningitis is one of the most severe infectious diseases in childhood. There are at least 1.2 million cases worldwide each year, causing 135 000 deaths. About half of these occur in Africa. Staff at primary healthcare facilities must be able to recognise symptoms and signs of meningitis, so that they can urgently refer suspected cases to hospital. To help them make these decisions, the World Health Organisation (WHO) has developed guidelines for identifying sick children in need of referral. These form part of the Integrated Management of Childhood Illness (IMCI). Two features of these guidelines are critical to their success: sensitivity and specificity. Sensitivity is the percentage of children with bacterial meningitis that is detected using these criteria. If the sensitivity is too low, this potentially life-threatening illness will be missed. Specificity is the proportion of children without bacterial meningitis who are correctly diagnosed as negative using these guidelines. If the specificity is too low, the system will be overburdened with unnecessary referrals. Parents will have to bear the time and expense of travel to a hospital that may be far away. How well do these guidelines perform in practice? What other signs and symptoms are good indicators of bacterial meningitis? Researchers studied 2097 children between the ages of two months and three years at hospitals in Banjul and Fajara, The Gambia. They found that:
The WHO guidelines perform well, but mean that more than 10 times as many children without meningitis would be referred than children with meningitis in this setting. However, some of these children had other conditions requiring hospital treatment, such as severe pneumonia. The researchers suggest that:
Source(s): Funded by: USAID; WHO; UNICEF; Children’s Vaccine Initiative; UNDP id21 Research Highlight: 22 January 2003
Further Information: Tel:
+41 22 791 2603 London School of Hygiene and Tropical Medicine, UK
Brian Greenwood Tel:
+44 (0) 207 299 4707 Medical Research Council Laboratoires, Gambia Other related links:
|
|
||||||||||||||
|
|
|
|
|
|
|||||||||||